ARTICLE | Company News
Pro Bono Bio, Spero deal
February 3, 2017 9:06 PM UTC
Spero acquired multiple antibacterial candidates from Pro Bono Bio. Spero said it will work with Pro Bono Bio’s Cantab Anti Infectives Ltd. company to co-develop the compounds to treat multidrug-resis...